RISCHIN, D.; BRUNGS, D. .; DAY, F. .; CHRISTIE, H. .; PATEL, V.; ADAMS, G. .; ESTES JACKSON, J.; DE LIZ VASSEN SCHURMANN, M.; KIRTBAYA, D. .; SHIN, T. .; HART, C.; STANKEVICH, E. .; LI, S.; LOWY, I. .; HAN, H. .; GONÇALVES, P. .; FURY, M. .; PORCEDDU, S. . C-POST protocol update: A Phase 3, randomized, double-blind study of adjuvant cemiplimab versus placebo post surgery and radiation therapy in patients with high-risk cutaneous squamous cell carcinoma. SKIN The Journal of Cutaneous Medicine, [S. l.], v. 7, n. 2, p. s173, 2023. DOI: 10.25251/skin.7.supp.173. Disponível em: https://jofskin.org/33014/index.php/skin/article/view/1996. Acesso em: 4 jul. 2024.